For patients with relapsed/refractory chronic lymphocytic leukemia, extended treatment with Imbruvica and Venclexta was found ...

GeoVax Labs (NASDAQ: GOVX) is a clinical-stage biotechnology company developing novel therapies and vaccines for solid tumor cancers and many of the ...

European Collaborations: GeoVax currently collaborates with multiple European-based service providers and UK academic partners, reinforcing the strategic rationale for establishing a presence within ...

Investigators found that lipid metabolism disruptions spark T-cell dysfunction in patients with chronic lymphocytic leukemia.

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax to Present at the 37th Annual Roth Conference 11.03.2025 / 14:06 CET/CEST The issuer is solely responsible for the content of this ...

GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and ...

Detailed price information for Adaptive Biotechnologies Corp (ADPT-Q) from The Globe and Mail including charting and trades.

Unique Fat Tissue Discovery Promotes Longevity and Sustains Exercise in AgingRutgers Health researchers have made discoveries ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License ...

Research into immunotherapy against cancer typically focuses on better recognition of cancer cells by the body's own immune ...

Research into immunotherapy against cancer typically focuses on better recognition of cancer cells by the body's own immune system. Researchers at Amsterdam UMC and Moffitt Cancer Center have taken a ...